Tanabe Pharma America
Pre-Approval PRO BETASlowing Activity
No new clinical trials started in 1-2 years. Monitor for changes in pipeline strategy. Last trial started: 4/18/2025
Pipeline by Phase
Therapeutic Focus
Clinical Trials (24)
Extension Study to Evaluate Safety and Tolerability of Oral Dersimelagon (MT-7117) in Subjects With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)
Started: 8/10/2021
Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria or X-Linked Protoporphyria
Started: 6/1/2020
Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Started: 10/29/2020
Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS
Started: 1/11/2022
Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALS
Started: 11/13/2020
Safety Study of Oral Edaravone Administered in Subjects With ALS
Started: 11/18/2019
INcreased Sun Exposure Without Pain In Research Participants With EPP or XLP
Started: 12/11/2023
MT-8554 for Reduction of Vasomotor Symptoms in Postmenopausal Women
Started: 10/9/2017
Long-term Safety and Efficacy Study of MT-8554 in Postmenopausal Women With Vasomotor Symptoms
Started: 4/18/2018
Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Erythropoietic Protoporphyria
Started: 7/5/2018
Safety and Efficacy Study of MT-2990 in Women With Endometriosis
Started: 1/15/2019
Study to Evaluate Efficacy, Safety, and Tolerability of MT-7117 in Subjects With Diffuse Cutaneous Systemic Sclerosis
Started: 2/5/2021
Study to Assess the Efficacy and Safety of MT-3921 in Subjects With Acute Traumatic Cervical Spinal Cord Injury
Started: 8/27/2021
A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Started: 4/18/2025
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-6345 in Healthy Subjects
Started: 1/15/2019
Study to Investigate Drug-Drug Interaction Between MT-7117 and Test Drugs in Healthy Subjects
Started: 3/23/2021
PK Study in Subjects With Renal Impairment (Severe and if Required Mild & Moderate) Compared to Subjects With Normal Renal Function
Started: 12/2/2020
Study to Assess Pharmacokinetics, Safety, and Tolerability of MT-7117 in Subjects With Normal and Impaired Hepatic Function
Started: 8/1/2019
Safety and Pharmacokinetics Study of MT-3921 in Spinal Cord Injury
Started: 4/19/2020
Relative Bioavailability and Drug-drug Interaction Study With MT-7117 and a Proton Pump Inhibitor
Started: 10/25/2018
Study to Evaluate the Effect of a Single Oral Dose of MT-7117 on the QT/QTc Interval in Healthy Subjects
Started: 1/12/2022